Characteristics of Adult Patients With Recessive Dystrophic Epidermolysis Bullosa

Trial ID or NCT#

NCT00904163

Status

not recruiting iconNOT RECRUITING

Purpose

Recessive dystrophic epidermolysis bullosa (RDEB) is a severe inherited blistering disease caused by the absence of type VII collagen. Patients with RDEB develop large, severely painful blisters and open wounds from minor trauma to their skin. We are screening RDEB subjects to determine additional characteristics of patients who survive to adulthood.

Official Title

Characteristics of Adult Patients With Recessive Dystrophic Epidermolysis Bullosa

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Inclusion Criteria:
  1. 1. Clinical diagnosis of RDEB by local dermatologist. 2. 18 years of age or more and willing to give consent.
Exclusion Criteria:
  1. 1. Medical instability limiting ability to travel to Stanford University Medical Center.
View All Criteria
Show Less

Investigator(s)

M. Peter Marinkovich, MD
M. Peter Marinkovich, MD
Dermatologist, Blistering disease specialist, Psoriasis specialist
Associate Professor of Dermatology
Paul A. Khavari, MD, PhD
Paul A. Khavari, MD, PhD
Dermatologist, Cutaneous oncology specialist, Medical oncologist
Carl J. Herzog Professor of Dermatology in the School of Medicine

Contact us to find out if this trial is right for you.

Contact

Emily Gorell, MS
650-721-7166

View on ClinicalTrials.gov